• Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics.
  • A high-level overview of Incyte Corporation (INCY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment...
  • Incyte is a global biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics.
  • Incyte is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel medicines to treat serious diseases.
  • About Incyte Corp. Sector. Health Care. Industry. Biotechnology. Incyte focuses on the discovery and development of small-molecule drugs.
  • INCY | Complete Incyte Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
  • Incyte’s largest acquisition to date was in 2022, when it acquired Villaris Therapeutics for $1.4B. Incyte has acquired in 3 different US states.